Nucleai
is an Illinois-based AI-driven spatial platform that provides solutions such as biomarker scoring, and genomic screening for the healthcare industry... Read moreNucleai
is an Illinois-based AI-driven spatial platform that provides solutions such as biomarker scoring, and genomic screening for the healthcare industry... Read more
News
Apr 22, 2025
Nucleai Blog
Nucleai Blog Nucleai Launches First-of-its-Kind Deep Learning Model to Automate Spatial Proteomics, Accelerating Biomarker Discovery for ADCs, Bispecifics, and Immunotherapy
Mar 22, 2025
Nucleai Blog
Nucleai Blog How AI and Spatial Biomarkers Are Transforming Antibody-Drug Conjugate Development
Nov 05, 2024
Business Wire
Press Release: Nucleai : Nucleai Highlights AI-Powered Spatial Biomarker Breakthroughs to Enhance Immunotherapy Success for Lung and Skin Cancer Patients at SITC 2024
Nov 01, 2024
Nucleai Blog
Nucleai Blog Top 10 Spatial Biology Companies of 2024
Oct 21, 2024
Nucleai Blog
Nucleai Blog How spatial AI is uncovering the hidden truths of breast cancer
Sep 07, 2024
Nucleai Blog
Nucleai Blog Research shows pathway to developing predictive biomarkers for immune checkpoint inhibitors
Jul 15, 2024
Drug Discovery and Development
Nucleai: How Nucleai's spatial biology tech aims to accelerate drug development
Jun 27, 2024
Nucleai Blog
Nucleai Blog 50 Companies Igniting Chicago's Startup Scene in 2024
Jun 27, 2024
Nucleai Blog
Nucleai Blog How AI startups working on clinical trials for cancer could find a breakthrough before big pharma
Jun 25, 2024
HIT Consultant Media
Nucleai: Proscia and Nucleai Partner to Integrate Predictive Biomarker Solutions
Nucleai Competitors
1
2
3
4
5
6
7
8
9
10